Goldman Sachs Upgrades Aramark On Potential For Rapid Rebound, Accelerated Growth

Loading...
Loading...

Aramark ARMK recorded lower-than-expected cash burn during the downturn and has greater sales opportunities on a COVID-19 recovery, according to Goldman Sachs.

The Aramark Analyst: Stephen Grambling upgraded Aramark from Neutral to Buy, raising the price target from $23 to $36.

The Aramark Thesis: All segments of Aramark could return to pre-COVID levels faster than what the consensus estimates reflect, Grambling said in the note.

“Given non-discretionary nature of services offered by ARMK (e.g. Food service and uniform service), we expect fundamentals to rebound as schools/malls/stadiums/office and other public spaces reopen,” the analyst wrote.

He added, “In our view, COVID-related disruptions will negatively impact operations of smaller regional food service players and in-sourcing arrangements given concerns around hygiene and safety standards. We believe these concerns could in-turn lead to share gains for institutional players like Aramark.”

Grambling noted the new contract wins indicate improved top-line and margin performance going ahead. If management is successful in improving retention rates and the expected synergies from the AmeriPride acquisition are realized, further margin expansion can be achieved.

ARMK Price Action: Shares of Aramark had appreciated by 3.4% to $28.92 at the time of publication Wednesday.

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsGoldman SachsStephen Grambling
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...